沃森生物：关于子公司收到冻干带状疱疹病毒mRNA疫苗《药物临床试验批准通知书》的公告

Core Viewpoint - Watson Bio has received approval for a clinical trial of a freeze-dried mRNA vaccine for herpes zoster, developed in collaboration with several partners [2] Company Summary - Watson Bio's subsidiary, Beijing Watson Innovation Biotechnology Co., Ltd., along with Yunnan Vaccine Laboratory Co., Ltd. and Yuxi Watson Biotechnology Co., Ltd., is involved in the development of the mRNA vaccine [2] - The vaccine development is a joint effort with Fudan University and Shanghai Blue Magpie Biomedical Co., Ltd. [2] Industry Summary - The approval from the National Medical Products Administration marks a significant step in the advancement of mRNA vaccine technology in the field of infectious diseases [2]